Lev Pharmaceuticals Inc.

Investigators at University of Chieti, Department of Paediatrics zero in on epilepsy in children.(Clinical report)
Biotech Week; 11/4/2009; 1247 words; ...tolerability of levetiracetam (LEV) as 'de novo' monotherapy...years. Therapy with LEV was started at 10 mg...abnormalities. Monotherapy with LEV was effective and well...Blackwell Publishing Inc., 350 Main St., Malden...Levetiracetam, Pediatrics, Pharmaceuticals, Seizures, Therapy...

Dyax Raising $38.5 Million To Fund Its DX-88 Trials.
BIOWORLD Today; 11/3/2009; 1162 words; ...Inc., J.P. Morgan Securities Inc. and Lazard Capital Markets LLC...stage programs are under way at Lev Pharmaceuticals Inc., ZLB Behring, Pharming Group...financing news: o Nuvo Research Inc., of Mississauga, Ontario...

Lev Raising $35 Million To Push C1 Inhibitor.
BIOWORLD Today; 11/3/2009; 1015 words; Washington Editor Lev Pharmaceuticals Inc. is expecting to raise $35 million...position." Jefferies & Co. Inc. acted as lead placement agent...agent and Morgan Joseph & Co. Inc. acted as co-placement agent for...

Dyax Plunges On Warning Of More Work With DX-88.
BIOWORLD Today; 11/3/2009; 1214 words; ...Specialty pharma firm Kos Life Sciences Inc., of Cranbury, N.J., last...BioWorld Today, Nov. 8, 2005.) Lev Pharmaceuticals Inc., of New York, started a Phase...based Alexion Pharmaceuticals Inc., fizzled in a Phase III study...

Clinic Roundup.
BIOWORLD Today; 11/3/2009; 1612 words; o Auxilium Pharmaceuticals Inc., of Malvern, Pa., said...diseases. o Cougar Biotechnology Inc., of Los Angeles, said Phase...treatment regimens. o Enzo Biochem Inc., of New York, said interim...In addition, plasma drug lev